Q4 2024 Results Conference Call March 19, 2025 8:30 AM ETCompany ParticipantsDan Ferry - IR, LifeSci AdvisorsOfer Gonen - ...

YAVNE, Israel, March 03, 2025 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced that it will release its ...

On examination, the left buttock decubitus ulcer had a black eschar with foul smell (Figure ... and bedside limited debridement with collection of a swab culture (BBL CultureSwab collection ...

Faster eschar removal: NexoBrid achieved complete eschar removal ... MediWound is advancing EscharEx ®, a promising candidate currently in Phase III development for the debridement of chronic wounds.

Faster eschar removal: NexoBrid achieved complete ... a promising candidate currently in Phase III development for the debridement of chronic wounds. Phase II clinical trials have shown EscharEx ...

These results reinforce NexoBrid’s clinical benefits as a rapid, effective, and non-surgical alternative for eschar removal in pediatric burn patients, validating its significance as a ...

In this study, we reported a synergistic strategy for the debridement and re-osteogenesis of contaminated titanium by using erythritol air abrasion (AA) coupled with an as-synthesized pH-responsive ...

Tick bites allow disease-causing microbes, including multiple species of Rickettsia bacteria, to pass from arthropods to humans. Being exposed to Rickettsia parkeri, for example, can cause a scab at ...